Harel Insurance Investments & Financial Services Ltd. Ligand Pharmaceuticals Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

$7.64 Billion
Q1 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Jan 23, 2020	SELL	$96.94 - $113.59 $48,470 - $56,795	-500 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$128.36 - $272.13 $64,180 - $136,065	500 New	500 $68,000

Others Institutions Holding LGND

# of Institutions

279

Shares Held

19M

Call Options Held

9.5K

Put Options Held

8.1K

Black Rock Inc. New York, NY

2.87M
Shares

$294 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

2.06M
Shares

$211 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

1.03M
Shares

$105 Million
0.06% of portfolio
Macquarie Group LTD Australia, C3

906K
Shares

$92.8 Million
0.12% of portfolio
Dimensional Fund Advisors LP Austin, TX

745K
Shares

$76.3 Million
0.02% of portfolio

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.73B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account